Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception
Review
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This paper reviews the use of antiandrogenic progestins for treating signs of androgenization and as a hormonal contraceptive.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
For treating signs of androgenisation (seborrhoea, acne, hirsutism, alopecia) ethinylestradiol in combination with an antiandrogenic progestin is the treatment of choice in adolescents and females throughout the reproductive years, since these combinations are also highly suitable for contraception. Under long-term treatment a favourable effect on carbohydrate and lipid metabolism can be seen due to the antiandrogenic properties of the progestins. These combinations also correct menstrual cycle disturbances and thus reduce the incidence of anaemia. In addition, the frequency of dysmenorrhoea and pelvic inflammatory disease will be lowered and there is a reduction in the risk of endometrial and ovarian cancer.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- The effects of Valette on skin and hair: a post-marketing surveillance study 2000
- THE EFFECTS OF VALETTE® ON SKIN AND HAIR: A POST‐MARKETING SURVEILLANCE STUDY 2000
- [New gestagens--advantages and disadvantages] 2001
- Effects of the dienogest-containing oral contraceptive Valette on skin and hair Results of a postmarketing surveillance study 1999
Cited by (3)
- Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate 2008
- The "newer" progestogens and postmenopausal hormone therapy (HRT) 2013
- Неконтрацептивные положительные эффекты комбинированных оральных контрацептивов 2013
References (22)
- Effects of the dienogest-containing oral contraceptive Valette on skin and hair Results of a postmarketing surveillance study via openalex
- [New gestagens--advantages and disadvantages] via openalex
- The effects of Valette on skin and hair: a post-marketing surveillance study via openalex
- THE EFFECTS OF VALETTE® ON SKIN AND HAIR: A POST‐MARKETING SURVEILLANCE STUDY via openalex
- W1973053346 via openalex
- W2058755936 via openalex
- W2073187238 via openalex
- W2087790510 via openalex
- W2103863392 via openalex
- W113438440 via openalex
- W2125800171 via openalex
- W2172389030 via openalex
- W2402629557 via openalex
- W2410970505 via openalex
- W2415291942 via openalex
- W2954498591 via openalex
- W2955313535 via openalex
- W4285719527 via openalex
- W2121080383 via openalex
- W153414115 via openalex
- W594441138 via openalex
- W1966587329 via openalex
Cited by (3)
- The "newer" progestogens and postmenopausal hormone therapy (HRT) 2013
- Неконтрацептивные положительные эффекты комбинированных оральных контрацептивов 2013
- Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate 2008
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:02:19.201584+00:00
- unpaywall
- last seen: 2026-10-26T06:31:53.434635+00:00
License: CC0
· commercial use OK